DIA vs IMDX
DIA (DIA) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
DIA (DIA) common stock.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
DIA does not have a complete income-statement cache yet.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
DIA currently screens at market cap $0. IMDX currently screens at market cap $0.
Not investment advice. Open the DIA and IMDX stock pages for the full models.
Not investment advice.